Magazine
ENEWS
SUBSCRIBE
WEBINARS
PODCASTS
EBOOKS
Edit submissions
Press releases
Media kit
Innovation Awards
Home
Compliance
cGMPs
Compliance Management
Regulatory Guidance
Validation
Articles
Key considerations for CGMP raw materials compliance
It is never too early to consider CGMP requirements in pharma
Beating FDA to the punch
A proactive approach to risk mitigation can help weed out quality issues before they become citations
Beyond ‘good’ practices
Pharma quality regulation has evolved beyond routine CGMP compliance toward a more holistic, proactive approach
Developing a cell and gene therapy packaging strategy
Optimal packaging and labeling solutions help ensure the delivery of safe, effective viral vector products
Toward a collaborative pharma ecosystem
A new biomanufacturing era demands that suppliers and manufacturers partner to efficiently bring new therapies to market
News
Intas hit with FDA warning letter
Biocon hit with multiple 483s
Ocugen could face $10,000 FDA non-compliance fine
FDA shares gene therapy research guidance
FDA hits Zydus with trio of observations
Aurobindo in trouble with the FDA again
Getting drug quality right the first time
CAPA remains an integral element of cost-effective quality management in pharma
Supporting continued process verification
CPV is required for regulatory compliance but can also provide process improvements
Juggling the regulatory complexities of global clinical trials
Deploying an automated process can help simplify safety and compliance information
Pharma’s hybrid inspection model
Four strategic steps to creating and executing a hybrid audit protocol
FDA year in review: 50 novel drug approvals and more
First-in-class and orphan drugs dominated the agency's 2021 approvals
Emergent BioSolutions: The path to re-emergence
How the Bayview plant put itself — and pandemic preparedness — on a better course
Pharma’s remote audits are here to stay
Distinctive strategies for doing remote audits successfully
Engineering Angles: Is your cold storage energy use through the roof?
How a commonly overlooked component of pharma facilities is impacting your bottom line
The fallout from Aduhelm
What our coverage of Biogen’s Alzheimer’s approval got right — and wrong — about the FDA’s decision
Adapting to Brexit in the pharma industry
Exploring the impact of Brexit on UK pharma supply chain
FDA pauses facility inspections due to omicron variant
Novo Nordisk obesity drug faces supply challenges following CMO issues
Struggling Teligent Pharma recalls super potent lidocaine, again
EU watchdog flags new safety concerns for J&J vaccine
Drugmakers score first 1st trial win in opioid suits
An unexpected pharma company ranked No. 1 in lobbying this summer
Glass pieces trigger Merck recall
Exclusive report says Novavax quality issues run deep
Pfizer cancer drug now comes with a warranty
In hot water with the FDA, Teva halts production at Calif. plant
Load More Content